Published in Biomacromolecules on March 08, 2011
Peptide-based subunit vaccine against hookworm infection. PLoS One (2012) 0.82
Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro. Int J Nanomedicine (2016) 0.76
Comparison of Fluorinated and Nonfluorinated Lipids in Self-Adjuvanting Delivery Systems for Peptide-Based Vaccines. ACS Med Chem Lett (2017) 0.75
Toxicity of antimony, copper, cobalt, manganese, titanium and zinc oxide nanoparticles for the alveolar and intestinal epithelial barrier cells in vitro. Cytotechnology (2016) 0.75
Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm (2010) 2.76
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol (2003) 1.88
The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia. J Am Coll Cardiol (2010) 1.82
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorg Med Chem (2006) 1.23
Modern subunit vaccines: development, components, and research opportunities. ChemMedChem (2013) 1.22
Ultrafast synthesis of ultrahigh molar mass polymers by metal-catalyzed living radical polymerization of acrylates, methacrylates, and vinyl chloride mediated by SET at 25 degrees C. J Am Chem Soc (2006) 1.18
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis (2007) 1.16
Self-adjuvanting lipopeptide vaccines. Curr Med Chem (2008) 1.10
Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother (2013) 1.10
Contact lens sensors in ocular diagnostics. Adv Healthc Mater (2014) 1.08
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol (2003) 1.06
Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr Drug Deliv (2006) 1.01
Cellular uptake of densely packed polymer coatings on gold nanoparticles. ACS Nano (2010) 0.98
Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano (2012) 0.97
Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology (2012) 0.94
Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angew Chem Int Ed Engl (2010) 0.94
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates. J Med Chem (2007) 0.94
Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use. Pharm Res (2008) 0.94
Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates. Bioorg Med Chem (2008) 0.92
Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res (2012) 0.92
Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. Curr Drug Deliv (2005) 0.91
Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine. J Control Release (2009) 0.90
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis (2006) 0.89
Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol (2005) 0.89
An influenza virus-inspired polymer system for the timed release of siRNA. Nat Commun (2013) 0.88
Reusable, robust, and accurate laser-generated photonic nanosensor. Nano Lett (2014) 0.87
Chemical methods for peptide and protein production. Molecules (2013) 0.87
Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. Exp Eye Res (2004) 0.87
A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun (2002) 0.87
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship. PLoS One (2012) 0.87
Rapidly reversible manipulation of molecular activity with dual chemical dimerizers. Angew Chem Int Ed Engl (2013) 0.86
Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships. Front Immunol (2013) 0.86
In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorg Med Chem (2008) 0.85
Synthesis and biological evaluation of an orally active glycosylated endomorphin-1. J Med Chem (2012) 0.85
Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infect Immun (2003) 0.85
Encapsulation of lipopeptides within liposomes: effect of number of lipid chains, chain length and method of liposome preparation. Int J Pharm (2005) 0.84
Peptide-based subunit nanovaccines. Curr Drug Deliv (2011) 0.84
Toll-like receptor agonists: a patent review (2011 - 2013). Expert Opin Ther Pat (2014) 0.84
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorg Med Chem (2008) 0.83
Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components. J Med Chem (2010) 0.83
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand. J Med Chem (2012) 0.83
Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insights. Pharm Res (2014) 0.83
Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery. Methods Mol Biol (2011) 0.83
Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. Bioorg Med Chem Lett (2007) 0.83
Overcoming the "coffee-stain" effect by compositional Marangoni-flow-assisted drop-drying. J Phys Chem B (2012) 0.82
Design, synthesis, and evaluation of a liposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin. J Med Chem (2004) 0.82
Simple synthetic toll-like receptor 2 ligands. Bioorg Med Chem Lett (2011) 0.82
Facile fabrication of core-shell-structured Ag@carbon and mesoporous yolk-shell-structured Ag@carbon@silica by an extended Stöber method. Chemistry (2013) 0.82
Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer. Biomacromolecules (2013) 0.82
Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin. Bioorg Med Chem (2005) 0.82
Peptide-based subunit vaccine against hookworm infection. PLoS One (2012) 0.82
Oral vaccine delivery--new strategies and technologies. Curr Drug Deliv (2009) 0.82
Peptide conjugation via CuAAC 'click' chemistry. Molecules (2013) 0.82
Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. Bioorg Med Chem (2010) 0.82
Biological properties and therapeutic potential of bilirubin. Mini Rev Med Chem (2003) 0.81
Novel cationic lipophilic peptides for oligodeoxynucleotide delivery. Bioorg Med Chem (2007) 0.81
Thermoresponsive worms for expansion and release of human embryonic stem cells. Biomacromolecules (2014) 0.81
Multifunctional nanoworms and nanorods through a one-step aqueous dispersion polymerization. J Am Chem Soc (2014) 0.81
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J Med Chem (2003) 0.81
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Immunol Cell Biol (2002) 0.81
Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines. Vaccine (2009) 0.81
Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2. Vaccine (2009) 0.81
Advances in peptide-based human papillomavirus therapeutic vaccines. Curr Top Med Chem (2012) 0.81
Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine (Lond) (2012) 0.80
Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation. PLoS One (2012) 0.80
Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation. J Med Chem (2006) 0.80
Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. Eur J Pharm Sci (2002) 0.80
Oral absorption and in vivo biodistribution of alpha-conotoxin MII and a lipidic analogue. Biochem Biophys Res Commun (2007) 0.80
Laser engineered graphene paper for mass spectrometry imaging. Sci Rep (2013) 0.80
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine. Nanomedicine (Lond) (2013) 0.80
Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products. Med Res Rev (2009) 0.80
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models. Int J Pharm (2006) 0.80
Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. Biochim Biophys Acta (2006) 0.80
Self-catalyzed degradable cationic polymer for release of DNA. Biomacromolecules (2011) 0.79
Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response. Curr Drug Deliv (2010) 0.79
Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage. J Med Chem (2004) 0.79
Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis. Bioorg Med Chem (2010) 0.79
Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm Res (2006) 0.79
Polymer nanocarrier system for endosome escape and timed release of siRNA with complete gene silencing and cell death in cancer cells. Biomacromolecules (2013) 0.79
Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines. J Med Chem (2007) 0.79
Self-catalyzed degradation of linear cationic poly(2-dimethylaminoethyl acrylate) in water. Biomacromolecules (2011) 0.79
Hierarchical mesoporous yolk-shell structured carbonaceous nanospheres for high performance electrochemical capacitive energy storage. Chem Commun (Camb) (2015) 0.79
Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes. J Med Chem (2002) 0.79
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines. J Med Chem (2008) 0.79
Intracellular trafficking pathways for nuclear delivery of plasmid DNA complexed with highly efficient endosome escape polymers. Biomacromolecules (2014) 0.78
Effect of polymer grafting density on silica nanoparticle toxicity. Bioorg Med Chem (2012) 0.78
Interaction of human arylamine N-acetyltransferase 1 with different nanomaterials. Drug Metab Dispos (2013) 0.78